Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03280108 · ClinicalTrials.gov registry record · NA
Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00
A NA study of Cataract, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 12
- Study locations
NCT03280108 is a NA study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 250 participants, above the 225-participant average among 83 other Cataract trials with a reported enrollment target (11% higher). The trial reports 12 study locations across 9 states.
The verdict
NCT03280108, a NA study of Cataract, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this clinical study is to compare the visual outcomes of the AcrySof IQ PanOptix Multifocal Intraocular Lens (IOL) Model TFNT00 against that of a monofocal lens, the AcrySof Monofocal IOL Model SN60AT, in order to demonstrate comparable distance vision and superior near and intermediate vision.
Conditions Studied
Interventions
- DEVICE AcrySof IQ PanOptix Multifocal IOL
- DEVICE AcrySof Monofocal IOL
Study Locations (12)
Texas
- Alcon Investigative Site - Houston
- Alcon Investigative Site - Hurst
- Alcon Investigative Site - Nacogdoches
Florida
- Alcon Investigative Site - Mt. Dora
- Alcon Investigative Site - Panama City
California
- Alcon Investigative Site - Fresno
New York
- Alcon Investigative Site - Poughkeepsie
South Carolina
- Alcon Investigative Site - Mt. Pleasant
South Dakota
- Alcon Investigative Site - Sioux Falls
Tennessee
- Alcon Investigative Site - Nashville
Utah
- Alcon Investigative Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2018-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03280108
The ClinicalTrials.gov registry entry for NCT03280108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 225-participant average among 83 other Cataract trials with a reported enrollment target (11% higher). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which AcrySof IQ PanOptix Multifocal IOL is the first listed.
NCT03280108 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Texas, Florida, California.
Frequently Asked Questions
What is clinical trial NCT03280108 about?
NCT03280108 is a clinical study titled "Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00". The purpose of this clinical study is to compare the visual outcomes of the AcrySof IQ PanOptix Multifocal Intraocular Lens (IOL) Model TFNT00 against that of a monofocal lens, the AcrySof Monofocal IOL Model SN60AT, in order to demonstrate comparable distance vision and superior near and intermedia...
What is the current status of trial NCT03280108?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2017-11-01. Estimated completion is 2018-09-27.
What conditions does trial NCT03280108 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT03280108?
The interventions under investigation include: AcrySof IQ PanOptix Multifocal IOL (DEVICE), AcrySof Monofocal IOL (DEVICE).
Who is sponsoring clinical trial NCT03280108?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03280108 being conducted?
This trial has 12 study locations across California, Florida, New York, South Carolina, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.